VigiLanz Announces Launch of New Clinical Trial Patient Identification Solution

VigiLanz Research will help hospitals and clinical research staff increase the number of patients identified for clinical trials, while reducing time and staff effort needed for manual screening

MINNEAPOLIS – October 11, 2022 – VigiLanz, a clinical software surveillance company, has announced the launch of a new solution that will empower researchers to accurately identify more eligible candidates for clinical trial enrollment in near real time. By automating the patient identification process, VigiLanz Research will provide help for clinical trial sites seeking to accelerate patient recruitment, meet time-sensitive enrollment targets, and gain insights on patients screened for eligibility.

Clinical trial screening is often an inefficient, costly, and labor-intensive process for clinical trial sites. More than half of all clinical trials fail to meet their enrollment targets, and nearly a quarter close because of insufficient patient enrollment.

“VigiLanz Research is streamlining the clinical trial recruitment process,” said Dr. David Goldsteen, Chief Executive Officer at VigiLanz, noting that for years clinical research sites have struggled to enroll enough patients. “This new solution leverages our two decades of clinical surveillance expertise into a system that empowers researchers to screen more qualified candidates. For hospitals, this increases the likelihood for clinical trial success, and for sponsors, this potentially saves millions of dollars and helps get products to market faster. Most importantly, it also connects people with opportunities for life-changing treatments that could help them live longer, healthier lives.”

VigiLanz recently partnered with Sharp HealthCare to implement VigiLanz Research for an acute cardiac clinical trial, which has a complex protocol and challenging patient enrollment requirements. VigiLanz Research automated screening processes using data in Sharp’s electronic health record (EHR), vastly increasing the number of patients screened to include all patients in all units, and reducing staff time needed to screen patients by 50%. This not only led to more patients being successfully enrolled in the study, but also improved staff satisfaction by giving them more time to focus on other high-value tasks.

“VigiLanz Research has not only improved our team’s efficiency but also has helped us make a difference in patients’ lives. This solution solved the biggest challenges we had in screening patients for this study – the short enrollment windows. With near real-time updates, we can now identify and enroll subjects who may have otherwise been missed,” said DeAnn Cary, PhD, Director of Research at the Outcomes Research Institute at Sharp HealthCare.

Sharp HealthCare and VigiLanz will be presenting an overview of the research process and the results at the WCG MAGI West 2022 conference in Las Vegas in mid-October. To learn more about VigiLanz Research, visit vigilanzcorp.com/research.

 

###

About VigiLanz
Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The organization is focused on transforming the delivery of quality care by aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes, and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.

 

For More Information
John Gonda
(616)-309-4888 
jgonda@sage-growth.com

VigiLanz Announces Winners of 2022 Vigi Awards

Award winners recognized for optimal and innovative use of clinical surveillance to support and improve patient care

MINNEAPOLIS – Aug. 15, 2022 –VigiLanz, a clinical surveillance company, today announced the winners of the annual Vigi Awards, which honor innovative hospitals throughout the United States.

The Vigi Awards recognize how hospitals have used clinical surveillance to enhance patient safety. The award winners are selected by VigiLanz based on nominations of individuals and teams submitted by VigiLanz customers. All award winners receive a donation to a charity of their choice.

“We are incredibly proud of this year’s Vigi Award winners, and it is our honor to recognize them for their amazing accomplishments and achievements,” said David Goldsteen, MD, VigiLanz CEO. “Demonstrated improvements in patient safety, outcomes, and cost savings matter to us all and it is our privilege to be able to partner with some of our country’s finest hospitals and health systems to improve lives.”

This year’s winners:

Infection Preventionist of the Year:

Adriana Jimenez, PhD, Infection Prevention Manager  – Jackson Health System, Florida
Recognized for using VigiLanz to track isolation and HAI activations, develop device and analysis reports, and customize real-time alerts.

Pharmacy Team of the Year:

Pharmacy Team – Freeman Health System, Missouri
Recognized for using VigiLanz to:

  • Build rules to quickly identify patients discharged with a new cardiology medication so that residents could provide appropriate medication education.
  • Create data mining searches to capture MRSA screens and culture results to validate discontinuation of vancomycin.
  • Identify patients with positive MRSA nasal screens that would benefit from mupirocin.

Safety Team of the Year:

Safety Team – Christus Health, Texas
Recognized for using VigiLanz to improve quality of medication error reports, enable error reporting standardization, and aid in the creation of meaningful action plans.

Rising Star (tie):

Pharmacy Team – Benefis Health System, Montana
Recognized for the development of VigiLanz rules to quickly identify the most severe patients that would likely benefit from a thorough comprehensive medical review, saving staff time.

Rising Star (tie):

Dechen Lama, IT Systems Administrator – Mount Sinai Health System, New York
Recognized for putting infection prevention ideas into action, including quickly creating new rules to identify and isolate COVID-19 and monkeypox patients and enable timely care.

5-Star Patient Care:

Pharmacy and Microbial Stewardship Team – Houston Methodist The Woodlands Hospital, Texas
Recognized for using rule-based alerts in conjunction with a pharmacist-driven MRSA protocol to provide timely de-escalation of antibiotics.

Stewardship:

Stewardship Team – Cincinnati Children’s Hospital Medical Center, Ohio
Recognized for enhancing long term health outcomes by using data collected by VigiLanz to identify pediatric patients allergic to Penicillin that may no longer be allergic and would benefit from allergy testing.

They Did What? Wow!:

Laura StinesInfection Prevention Data Analyst – Cone Health System, North Carolina
Recognized for using VigiLanz to automatically populate HAI dashboards, providing more data to drive decision making and analyze trends, and reducing risk of manual entry errors.

Great Catch!:

Continental Division – HCA Healthcare, Colorado
Recognized for using data captured by VigiLanz to investigate care patterns, enable investigations, and catch drug diversions to advance patient safety.

“VigiLanz allows a much more streamlined approach to medication compliance compared to pulling the data from the electronic health record directly. The way VigiLanz collates the information into workable documents means we can also create visual aids, such as graphs and tables, to demonstrate trends or data,” said Holly Monatt, Vice President of Pharmacy Services at HCA Healthcare Continental Division. “The time we spend interpreting and reviewing data is so much more meaningful because of the efficiencies VigiLanz provides us for actual data gathering.”

For more information on the Vigi Awards and award winners, please visit the VigiLanz website.

 

###

About VigiLanz
Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The organization is focused on transforming the delivery of quality care by aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes, and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.

 

For More Information
John Gonda
(616)-309-4888 
jgonda@sage-growth.com

How One Hospital Successfully Transitioned to a New Patient Safety Reporting System

Learn how Community Health Network, a multi-hospital system serving Central Indiana, underwent a successful transition in patient safety event reporting software in the midst of the pandemic.

Presented in May 2022 by VigiLanz and M. Danielle Dillon, MHL, BSN, RN, CCRN-K, Network Blood Management Director at CHN.

Key webinar learning points:

  • The criteria used to evaluate vendors based on identified problems
  • Lessons and tips for successful implementation, training, and launch processes
  • How the new reporting system positively impacted many areas of the hospital

 

Transforming hospital safety: How the pandemic is serving as a catalyst for change

Held at the two-year anniversary of the World Health Organization’s declaration of the COVID-19 pandemic, this webinar panel of hospital leaders discussed the challenges they’ve faced in the last two years — as well as the steps they are taking to improve the future of hospital safety for patients, staff and visitors.

The panel of infection preventionists, pharmacists and hospital executives also shared insights from the fourth annual Hospital Patient Safety Report. Based on a January 2022 survey of 100 hospital leaders, the report reveals hospitals’ biggest safety challenges and priorities.

Key webinar learning points:

  • Safety challenges exposed by the pandemic
  • Safety improvements made at the outset of the pandemic that had a long-term impact
  • Leading hospitals’ planned safety improvements and priorities for 2022
  • How hospitals are preparing for future pandemic-like situations

 

A New Vision For Hospital Safety

a new vision for hospital safety infographic

The Steps Leading Hospitals Are Taking To Overcome The Safety Challenges

What safety challenges are on hospitals’ watch lists, and what are they doing to overcome them? This infographic—featuring insights gathered from VigiLanz’s Hospital Patient Safety Report 2022, Becker’s Hospital Review, JAMA, and more—has answers.

VigiLanz Releases New Industry Report Highlighting How the Pandemic is Impacting Hospital Safety

Two years after the World Health Organization declared COVID-19 a pandemic, how is the patient, staff, and visitor safety landscape changing, and what might the future bring?

MINNEAPOLIS, March 23, 2022VigiLanz, a clinical surveillance company, today announced the release of its fourth annual Hospital Patient Safety Report.

The Hospital Patient Safety Report, released annually since 2019, serves as a barometer of safety performance within U.S. hospitals and reveals how safety challenges, initiatives, and priorities are evolving. The 2022 report, which also highlights the impact of the pandemic on patient, staff, and visitor safety, is based on an independent survey of 100 hospital and health system leaders conducted in January 2022 by Sage Growth Partners.

Nearly one out of three hospital executives and clinical leaders surveyed reported that their organization is not doing enough to address pandemic-exposed vulnerabilities, and nearly one out of five says pandemic-related challenges such as staff burnout and shortages are putting patients’ lives in jeopardy.

While many hospital executives and clinical leaders see significant safety problems within their organizations, the survey also reveals that most are advancing and prioritizing improvements, with about three-quarters saying the pandemic has made improving patient, staff, and visitor safety a higher priority,” said VigiLanz Chairman and CEO David Goldsteen, MD. “We’re excited to see the positive impact that this commitment to positive change will have on everyone within healthcare organizations.”

Among the report’s key findings and insights:

  • 33% of hospital executives and clinical leaders say their organization hasn’t done enough to address pandemic-exposed safety problems.
  • 86% say burnout has led to a decline in patient safety, while 21% say it has caused patient deaths.
  • 42% indicate their rate of hospital-acquired infections has increased over the past 12 months.
  • 78% say the pandemic has led to new patient safety improvement initiatives, 77% say it has led to staff safety improvement initiatives, and 72% say it has led to visitor safety improvement initiatives.

“Hospital leaders are facing several safety-related challenges, but the good news is they are embracing new initiatives—and allocating more resources—to meet them,” said Dr. Hayley Burgess, Chief Clinical Officer, VigiLanz.

She also noted that 64% of respondents shared that the pandemic has resulted in a higher budget for staff safety improvements, 58% report enhanced budgeting for patient safety improvements, and 49% for visitor safety improvements.

“As hospitals consider various safety improvement initiatives, implementing clinical surveillance technology is a good choice to enhance identification of safety issues which in turn expedites the improvement cycle,” said Dr. Burgess.

Overall, the Hospital Safety Report shows that healthcare leaders agree that clinical surveillance technology positively impacts hospital safety, regardless of whether they are currently using the technology.

Among survey respondents who already use the technology, there is widespread agreement about the benefits. These span from an increased ability to identify and manage safety events to identifying infections or outbreaks sooner. In addition, 92% of hospital executives and clinical leaders whose organizations already incorporate technology indicate that it is supporting their hospital’s efforts to respond to the pandemic.

“The 2022 Hospital Patient Safety Report provides a unique opportunity for the industry to begin measuring how the pandemic continues to impact national hospital safety trends,” said Dan D’Orazio, CEO, Sage Growth Partners. “Staffing shortages, clinical burnout, infection prevention, and pharmacy-related challenges have had an enormous impact on hospital safety, but there is a substantial opportunity to overcome these challenges, and I believe the industry will do so.”

For more information and key takeaways on the survey findings, including how the pandemic is impacting and changing how hospitals are approaching safety within key areas such as infection prevention, pharmacy surveillance, and antimicrobial stewardship, please visit https://vigilanzcorp.com/hospital-patient-safety-report-2022/.

About VigiLanz

Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on transforming the delivery of quality care by aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes, and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.

About Sage Growth Partners

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing.

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

VigiLanz Ranked No. 1 by KLAS Research for Pharmacy Surveillance for Fifth Consecutive Year

The clinical surveillance company most trusted by hospitals is recognized as Best in KLAS, totaling 11 KLAS awards over 5 consecutive years

MINNEAPOLIS, FEBRUARY 8, 2022VigiLanz, a clinical surveillance company, today announced that it has earned the 2022 Best in KLAS designation from KLAS Research for Pharmacy Surveillance.

This is the fifth year that VigiLanz has been recognized by KLAS as a leader, bringing its total count of KLAS awards to 11. These awards span various categories, including Infection Control and Monitoring and Antimicrobial Stewardship, the latter of which KLAS folded into Pharmacy Surveillance last year.

The VigiLanz clinical surveillance platform, which houses VigiLanz’s Pharmacy Surveillance solution, converts disparate EHR data into uniform, actionable intelligence that helps clinicians make smarter business decisions while delivering the highest quality patient care. Earning a score of 92.6, VigiLanz Pharmacy Surveillance continuously monitors data from the EHR and ancillary clinical systems to maximize efficiencies, standardize practices, and improve medication safety. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“I am very happy with VigiLanz Pharmacy Surveillance. We will definitely keep using it. It is easy to use, and it has made a world of difference. This is the first time we have had a product like this. VigiLanz Pharmacy Surveillance replaced the manual process that we were using through our EHR.”

    • Manager, October 2021, klasresearch.com

 

In addition to pharmacy surveillance, VigiLanz offers a variety of solutions on its clinical surveillance platform, including Infection Prevention, Antimicrobial Stewardship, Safety Surveillance, Risk and Claims, Audit, Clinical and Quality Services, and Corporate Services. These solutions create an umbrella of protection for hospitals and their patients, facilitating a system-wide approach that reduces risks, improves safety, enhances patient and staff satisfaction, and streamlines workflows.

“As our hospital customers continue to face enormous challenges as a result of the ongoing COVID-19 pandemic, we are extremely proud to once again receive national recognition from KLAS for the fifth consecutive year,” said VigiLanz Chairman and CEO David Goldsteen, MD. “Our customers continue to rely on us during the most critical times — from triaging COVID-19 cases, to monitoring the use of life-saving pharmaceuticals during a shortage, or saving clinicians valuable time by providing real-time alerts and reports so they can focus more on caring for their patients. It’s our job to help hospitals keep patients safe, and we’re honored to once again see overwhelmingly positive reactions regarding the platforms, products and solutions that we offer.”

Best in KLAS is a recognition given to vendors for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations. Rankings are based on customer surveys of North American healthcare leaders, administrators, clinicians, and others who interact with the solutions.

Selected commentary collected about VigiLanz Pharmacy Surveillance, January 2022 © 2022 KLAS. Visit klasresearch.com for a complete view.

 

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

VigiLanz Announces L. Hayley Burgess, Pharm.D, MBA, BCPP, CPPS as New Chief Clinical Officer

Proven industry leader brings substantial clinical expertise and patient safety insights to further support company growth and innovation, while exceeding hospital client expectations

 

hayley burgessMINNEAPOLIS, August 9, 2021 — VigiLanz, a life-saving clinical surveillance company, today announced that Dr. L. Hayley Burgess has been named as the organization’s new Chief Clinical Officer. In this role, Dr. Burgess will provide leadership oversight and strategic vision for the VigiLanz clinical teams, as well as lead regulatory affairs activities, and support clinical innovations and product development.

Dr. Burgess has more than two decades of pharmacy services, patient safety, and medication management system experience and has spearheaded successful initiatives to enhance medication safety and risk mitigation, most recently served as AVP, Pharmacy Services for HCA Healthcare. In this role, she developed the pharmacy services and medication management strategy and vision for 185 hospital and 120 ambulatory surgery center programs.

While at HCA, her accomplishments included leading the antimicrobial management program (achieving a yearly fifty percent antimicrobial drug spend reduction over baseline), leading the clinical pharmacist workflow program that reduced coded adverse drug events by sixty percent, and improving financial resiliency related to high-cost medications (resulting in millions of dollars in drug spend waste). Her team recently won the Institute for Safe Medication Practices (ISMP) Cheers Award for the Clinical Pharmacist Workflow Model.

Previously she served as Director of Performance Improvement at TMIT, a medical research organization, and as a Supervisor of Clinical Pharmacy Specialties at Kaiser Permanente Colorado Division.

“We are excited to have a clinician as experienced and talented as Hayley join our leadership team. Her recent leadership role at one of the nation’s largest healthcare providers—and her many accomplishments in pharmacy and care delivery system leadership—speaks to her ability to augment with unparalleled knowledge, innovation and strategy,” said David Goldsteen, Chairman and CEO. “She has a broad, real-world vision and extensive knowledge that will greatly contribute to our team as we continue to push the boundaries to improve patient outcomes, clinical efficiency and operational efficiency.”

Dr. Burgess serves as a charter member of the Tennessee Hospital Association’s Medication Use and Safety Innovations Committee and Adverse Drug Event Prevention taskforce, in addition to a charter member of the Board of Pharmacy Specialties Employer committee. She is also part of the CDC and Harvard Pilgrim research team leading the INSPIRE trial for smart antimicrobial decision prompts for prescribers.

Dr. Burgess earned her Doctor of Pharmacy degree from Samford University and her Healthcare MBA from Western Governors University. She completed a post-doctoral residency and clinical science research fellowship in Neurobiology and Psychiatric Pharmacology/Pharmacoeconomics at the University of Texas Health Science Center in San Antonio. She is a Board-Certified Psychiatric Pharmacist (BCPP) and is a Certified Professional in Patient Safety (CPPS). Dr. Burgess is also an affiliate faculty member at Lipscomb University, the University of Tennessee, and Belmont University’s College of Pharmacy.

“I am honored to join the exceptional VigiLanz leadership team and further the mission of providing innovative clinical surveillance services to the healthcare industry,” said Dr. Burgess. “The dynamic software solutions we provide save lives, mitigate harm, and positively impact clinical services in hospitals and clinics with an intuitive workflow design. I am committed to our future success and the leadership role our organization’s technology solutions play in redefining clinical workflows, providing exceptional services and designing the future of patient safety event surveillance. VigiLanz’ ability to design meaningful clinical and safety measures, trends, and dashboards for healthcare system consumption is revolutionary!”

 

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient and outpatient care.

 

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

Safety Event Detection and Management: 3 Things Every Hospital Needs

Most hospitals use basic safety event reporting mechanisms to monitor safety events and identify improvement opportunities. But the effectiveness of these mechanisms is often hindered by three key barriers:

  1. Lack of automated event detection  
  2. Cumbersome documentation workflows 
  3. Limited reporting and analytics capabilities 

When safety event reporting solutions lack these three features, events are less likely to be reported in a timely manner. Worse, many safety events may be missed altogether. That means hospitals are more likely to experience the same safety problems in the future.  

Here’s more on how your hospital can overcome the three key barriers outlined above. 

Barrier #1: Lack of automated event detection  

Why it’s a problem: In most hospitals, the only method to capture and report safety events is through staff member reporting. This single-method approach often results in delayed reporting and failure to report events at all. For example, staff may not have time to report events, forget to report them, or choose not to report them due to fear of punitive action. 

How to overcome it: Automated event detection 

What it is: Automated event detection, also known as electronic case finding, is the process of identifying safety events that have occurred using software algorithms and/or rules engines. This process, which can be used in combination with staff reporting, ensures more safety events are captured more quickly. 

Automated event detection requires near-real time standardized and normalized data. Cases are found using numerous types of data feeds including, but not limited to, the EMR, nursing notes, imaging, diagnosis and problem lists, medication administrations, and more.  

The best event auto-detection solutions capture all types of safety events, including those that affect patients, employees, and visitors.  

 

Automated Event Detection In Action: Narcan Example

VigiLanz Safety Surveillance uses several criteria to automatically detect safety events. For example, if the following criteria are met for the use of Narcan, a safety event is documented: 

  1. The administration of Narcan in a patient who has recently received morphine. 
  2. The patient has evidence of respiratory depression via a decrease in respiratory rate or oxygen saturation. 
  3. The patient is not currently located in a procedure area where the use of Narcan is more routine.  

Barrier #2: Cumbersome documentation workflows 

Why it’s a problem: Event reporting should not be difficult for your staff members. The harder it is for them to document events, the more likely it is that they will document them incorrectly or won’t document them at all. Cumbersome workflows also increase the likelihood that the reporting will lack the thoroughness necessary to support investigative processes. 

How to overcome it: Event form auto-population 

What it is: The same data feeds used to automatically detect safety events can also help streamline documentation workflows for staff members. When real-time standardized and normalized data is pulled from these data feeds, that data can be populated into event reporting forms automatically. This significantly reduces staff time spent filling out event forms.

This real-time data can provide additional benefits, including enhanced reporting accuracy and more efficient communication regarding safety events. For example, if certain thresholds are met, the solution can automatically trigger real-time alerts to relevant staff members.    

“Identifying patient safety opportunities is a fundamental first step to preventing harm and improving patient care, which is why hospitals promote safety event reporting.”

– James Hoffman, PharmD, Chief Patient Safety Officer, St. Jude Children’s Research Hospital

Barrier #3: Limited reporting and analytics capabilities 

Why it’s a problem: In order to foster continual safety improvements, the safety event reporting mechanism must make it easy for healthcare leaders to investigate and act on documented information via reporting and analytics tools. Unfortunately, this is another area in which many safety event reporting mechanisms fall short. 

How to overcome it: Automated event detection + form auto-population + reporting tools 

What it is: As previously noted, automated event detection and form auto-population are critical to ensuring safety events are identified quickly and documented properly. However, these capabilities are also key to enabling the quick and thorough analysis and investigation of safety events. 

Without automated event detection and auto-population, even the best safety event reporting and analytics platforms stumble. Since organizations without automated detection and auto-population tend to capture fewer events and fewer details related to events, their reporting and analytics platforms are working with incomplete data. That means these organizations are missing key safety trends and improvement opportunities. 

When automated event detection is used in tandem with a robust set of reporting and analytics tools—such as timelines, cause mapping, solution maps, and fishbone diagrams—hospitals can identify more safety events and safety trends more quickly. This helps them intervene faster to prevent future problems. 

“Hospitals increasingly recognize that they must find ways to intervene more quickly when safety events occur. The longer the delay in intervention, the more likely it is a similar event will occur again. Automated event detection and alerts keep patients safer because hospitals can intervene faster.”

– Karen Biesack, Senior Quality and Safety Specialist, VigiLanz

VigiLanz Dynamic Safety Surveillance is a modern, configurable platform for identifying, reporting, managing, and communicating safety events. By incorporating the above capabilities, VigiLanz enables organizations promote a culture of safety while reducing adverse events. Learn more at vigilanzcorp.com/safety-surveillance.

VigiLanz Launches Intelligent Audit Solution for Hospitals, Streamlining and Automating Processes and Expanding #1 Rated Clinical Surveillance Platform

Configurable forms, automated workflows, and real-time reports help hospitals and health systems strengthen quality oversight and scale quality improvement initiatives  

MINNEAPOLIS, June 29, 2021 — VigiLanz, a clinical surveillance company, today announced the launch of a new audit solution built on VigiLanz’s award-winning enterprise software platform. The new solution, VigiLanz Audit, complements VigiLanz’s existing safety, quality, and risk products by streamlining, automating, and optimizing audit processes. In addition to saving time and resources, VigiLanz Audit helps hospitals quickly identify emerging risks and ensure continuous quality improvements.

Recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance for the fourth consecutive year, VigiLanz applied its more than 20 years of complex, clinical data experience to create VigiLanz Audit.

The solution streamlines the full audit lifecycle, including case identification, data collection and analysis, and decision-making. It helps create and maintain an efficient, repeatable audit process, so hospitals can effectively evaluate improvement initiatives and scale programs when appropriate.

“VigiLanz Audit helps address significant challenges hospitals face related to time-consuming, inconsistent, and resource-burdensome audits,” said Stacy Pur, VigiLanz’s VP of Product Development, noting that many hospitals still rely on paper- and excel-based audit workflows.

VigiLanz Audit helps hospitals complete audits more efficiently and accurately, and as a result, they have more bandwidth to expand their audit and quality improvement programs.

“Previously, hospitals were only able to make improvements as fast as their manual processes and limited staffing resources would allow. Our new solution is a game-changer for patient safety and patient quality. It leads to a cycle of continuous improvement,” said Pur.

VigiLanz Audit supports every type of quality assurance (QA) and quality improvement (QI) healthcare audit, including clinical, environmental, billing compliance, and accreditation readiness. Key features include:

  • A comprehensive library of ready-to-go and configurable audit forms
  • Automated identification of eligible cases and automated case reminders
  • Accurate and repeatable processes
  • One-click population queries to determine appropriate sample size
  • Auto-populated forms and conditional form fields
  • Seamless data integration
  • Real-time audit reports and dashboards for enterprise-wide visibility

The launch of VigiLanz Audit follows the release of three other VigiLanz solutions: VigiLanz Risk and ClaimsVigiLanz Compliance, and VigiLanz Patient Relations. Learn more about these solutions, and VigiLanz Audit, at VigiLanzcorp.com.

VigiLanz earned Best in KLAS in the “2021 Best in KLAS: Software and Services” report, released February 2, 2021. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.


About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.



Media Contact
John Gonda
(616)-309-4888
jgonda@sage-growth.com